Efficacy of rivaroxaban for thromboprophylaxis after knee arthroscopy (ERIKA): A phase ii, multicentre, double-blind, placebo-controlled randomised study

Thrombosis and Haemostasis

Volumn 116, Issue 2, 2016, Pages 349-355

  Camporese, Giuseppe ^a   Bernardi, Enrico ^b   Noventa, Franco ^a   Bosco, M ^j   Monteleone, G ^j   Santoro, L ^j   Bortoluzzi, C ^k   Freguja, S ^k   Nardin, M ^k   Marullo, M ^l   Zanon, G ^l   Mazzola, C ^m   Damiani, G ^m   Maniscalco, Pietro ^g   Imberti, Davide ^g   Lodigiani, C ⁿ   Becattini, Cecilia ⁱ   Tonello, C ^j   Agnelli, Giancarlo ⁱ   Santoliquido, A ^j   Di Giorgio, A ^j   Nicolardi, E ^j   Biondi, G ^j   Fieri, C ^j   Dall'Acqua D ^j   De Matthaeis, A ^j   Giannotta, L ^j   Masciangelo, M ^j   Taccardo, G ^j   De Vitis, R ^j   Militerno, A ^j   Serpieri, S ^j   Cilli, V ^j   Parisi, R ^k   Azzaretti, A ^l   Gori, A ^m   Cassola, P ^m   Zabzuni, D ^k   Volpi, P ⁿ   Bait, C ⁿ   Vitali, S ^o   Vedovati, M C ^o   Di Micco, P ^p   Dimaro, P ^p   Ghirarduzzi, A ^k   Veropalumbo, R ^k   more..

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b Hospital of Conegliano   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d Hospital of Venice   (Italy)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^f GALLIERA HOSPITAL   (Italy)

^g Hospital of Piacenza   (Italy)

^h HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

ⁱ UNIVERSITY OF PERUGIA   (Italy)

^j UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

^k Civic Hospital   (Canada)

^l San Matteo IRCSS Hospital   (Italy)

^m Gal Liera Hospital   (Italy)

ⁿ Humanitas IRCSS Hospital   (Italy)

^o SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^p NICU Fatebenefratelli Hospital   (Italy)

more..

Author keywords

Arthroscopy; Bleeding; Prophylaxis; Rivaroxaban; Venous thromboembolism

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; RIVAROXABAN; BLOOD CLOTTING FACTOR 10A INHIBITOR;

ADULT; ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION; ARTICLE; COLOR DOPPLER FLOWMETRY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; FEMALE; HUMAN; KNEE ARTHROSCOPY; MAJOR CLINICAL STUDY; MALE; MENISCECTOMY; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SKIN MANIFESTATION; THROMBOSIS PREVENTION; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; ARTHROSCOPY; CLINICAL TRIAL; KNEE; MIDDLE AGED; SURGERY; VEIN THROMBOSIS;

ADULT; ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION; ARTHROSCOPY; DOUBLE-BLIND METHOD; FACTOR XA INHIBITORS; FEMALE; HUMANS; KNEE JOINT; MALE; MENISCECTOMY; MIDDLE AGED; RISK FACTORS; RIVAROXABAN; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84980319977     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH16-02-0118     Document Type: Article

References (38)

1. Hoppener MR, Ettema HB, Henny CP, et al. Low incidence of deep vein thrombosis after knee arthroscopy without thromboprophylaxis A prospective cohort study of 335 patients. Acta Orthop Scand 2006; 77: 767-771.
2. Graham WC, Flanigan DC. Venous thromboembolism following arthroscopic knee surgery: a current concepts review of incidence, prophylaxis and preoper-ative risk assessment. Sports Med 2014; 44: 331-343.
3. Demers C, Marcoux S, Ginsberg JS, et al. Incidence of venographically proved deep vein thrombosis after knee arthroscopy. Arch Intern Med 1998: 158: 47-50.
4. Dahl OE, Gudmundsen TE, Haukeland L. Late occurring clinical deep vein thrombosis in joint operated patients. Acta Orthop Scand 2000; 71: 47-50.
5. Jareguito JW, Greenwald AE, Wilcox JF, et al. The incidence of deep venous thrombosis after arthroscopic knee surgery. Am J Sports Med 1999; 27: 707-710.
6. Delis KT, Hunt N, Strachan RK, Nicolaides AN. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy. Thromb Hae-most 2001; 86: 817-821.
7. van Adrichem RA, Nelissen RGHH, Schipper IB, et al. Risk of venous thrombosis after arthroscopy of the knee: results from a large population based case-control study. J Thromb Haemost 2015; 13: 1441-1448.
8. Wirth T, Schneider B, Misselwitz F, et al. Prevention of venous thromboembol-ism after knee arthroscopy with low molecular weight heparin (Reviparin): results of a randomised controlled trial. Arthroscopy 2001; 17: 393-399.
9. Schippinger G, Wirnsberger GH, Obernosterer A, et al. Thromboembolic complications after arthroscopic knee surgery. Incidence and risk factors in 101 patients. Acta Orthop Scand 1998; 69: 144-146.
10. Michot M, Conen D, Holtz D, et al. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomised trial of prophylaxis with low-molecular weight heparin. Arthroscopy 2002; 18: 257-263.
11. Camporese G, Bernardi E, Prandoni P, et al. Low-molecular-weight heparin versus graduated compression stockings for prevention of venous thromboembol-ism after knee arthroscopy. A randomised trial. Ann Intern Med 2008; 149: 73-82.
12. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of Venous Thromboembol-ism. The 8th ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2008; 133: 381S-453S.
13. Ageno W, Dentali F, Imberti D. A survey of thrombosis prophylaxis use in patients undergoing arthroscopic surgery. J Thromb Haemost 2004; 2: 1901-1902.
14. Turpie AG, Lassen MR, Eriksson BI, et al. Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies. Thromb Haemost 2011; 105: 444-453.
15. Prins MH, Lensing AW, Bauersachs R, et al. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomised studies. Thromb J 2013; 11: 21.
16. Patel MR, Mahaffey KW, Garg J, et al. ROCKET AF Investigators. N Engl J Med 2011; 365: 883-891.
17. Munoa L, Gonzalez AB, Diaz de Rada P, et al. Rivaroxaban is as efficient and safe as bemiparin as thromboprophylaxis in knee arthroscopy. Musculoskelet Surg 2014; 98: 21-25.
18. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap) - A meta data-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377-381.
19. Committee for Proprietary Medicinal Products. Points to consider on clinical investigation of medicinal products for prophylaxis of intra- and post-operative venous thromboembolic risk. London: European Agency for the Evaluation of Medicinal Products; 2000. Available at http://www.emea.europa.eu/pdfs/human/ewp /070798en.pdf. Accessed on May 20, 2008.
20. Schulman S, Kearon C, on behalf of the subcommittee on control of anticoagu-lation of the scientific and standardisation committee of the International Society On Thrombosis and haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3: 692-694.
21. Torbicki A, Perrier A, Konstantinides S, et al. ESC Committee for Practice Guidelines (CPG). Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29: 2276-2315.
22. Cogo A, Lensing AW, Koopman MM, et al. Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. Br Med J 1998; 316: 17-20.
23. Ilahi OA, Reddy J, Ahmad I. Deep venous thrombosis after knee arthroscopy: a meta-analysis. Arthroscopy 2005; 21: 727-730.
24. Ramos J, Perrotta C, Badariotti G, et al. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy. Cochrane Database Syst Rev 2008; 2: CD005259.
25. Fleiss, J. L. Statistical Methods for Rates and Proportions. New York: John Wiley & Sons Inc., 1981: pp. 24-26.
26. Chernick, M. R., Liu, C. Y. The saw-toothed behavior of power versus sample size and software solutions: single binomial proportion using exact methods. Am Statistician 2002; 56: 149-155.
27. Miettinen OS, Nurminen M. Comparative analysis of two rates. Statistics Med 1985; 4: 231-236.
28. Newcombe R. Interval estimation for the difference between independent proportions. Statistics Med 1998; 17: 873-890.
29. Koopman PAR. Confidence limits for the ratio of two binomial proportions. Biometrics 1984; 40: 513-517.
30. Gart JJ, Nam J. Approximate interval estimation for the difference in binomial parameters: correction for skewness and extension to multiple tables. Biometrics 1990; 46: 637-643.
31. Gart JJ, Nam J. Approximate interval estimation for the ratio of binomial parameters: a review and correction for skewness. Biometrics 1988; 44: 323-338.
32. Kahn SR, Ducruet T, Lamping DL, et al. Prospective evaluation of health-related quality of life in patients with deep venous thrombosis. Arch Intern Med 2005; 165:1173-1178.
33. Turpie AG, Lassen MR, Davidson BL, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet 2009; 373: 1673-1680.
34. Prandoni P, Noventa F, Ghirarduzzi A, et al. The risk of recurrent venous throm-boembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica 2007; 92: 199-205.
35. Sun Y, Chen D, Xu Z, et al. Incidence of symptomatic and asymptomatic venous thromboembolism after elective knee arthroscopic surgery: a retrospective study with routinely applied venography. Arthroscopy 2014; 30: 818-822.
36. Lassen MR, Ageno W, Borris LC, et al. for the RECORD3 Investigators. Riva-roxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty. N Engl J Med 2008; 358: 2776-2786.
37. Goodacre S, Sampson F, Thomas S, et al. Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis. BMC Medical Imaging 2005; 5: 6.
38. Struijk-Mulder MC, Ettema HB, Verheyen CC, et al. Deep vein thrombosis after arthroscopic anterior cruciate ligament reconstruction: a prospective cohort study of 100 patients. Arthroscopy 2013; 29: 1211-1216.